Jun 17, 2019 / 01:00PM GMT
Operator
Good day, everyone, and welcome to the Pfizer Analyst and Investor Call to discuss proposed acquisition of Array BioPharma. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead.
Charles E. Triano - Pfizer Inc. - SVP of IR
Thank you, operator. Good morning everyone, and thanks for joining us today on short notice to review our proposed acquisition of Array BioPharma, which we announced this morning. Today, I'm joined by Mikael Dolsten, our Head of R&D; Frank D'Amelio, our CFO; Andy Schmeltz, Global President and General Manager of Pfizer Oncology; and Chris Boshoff, our Oncology Chief Development Officer.
The slides that will be presented on the call can be viewed on our website at pfizer.com/investors.
As typical, before we start, I'd like to remind you that our discussions during the call will include forward-looking statements that are subject to risks and uncertainties that could cause the actual results to differ materially
Pfizer Inc to Acquire Array BioPharma Inc Call Transcript
Jun 17, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers